Literature DB >> 6154120

Interaction of glucosyltransferase from Streptococcus mutans with various glucans.

S Hamada, M Torii.   

Abstract

Cell-free glucosyltransferase of Streptococcus mutans strain B13 (serotype d) exclusively synthesized water-insoluble glucan from sucrose. The insoluble glucan possessed strong glucan-associated glucosyltransferase activity even after extensive washing and lyophilization. Furthermore, cell-free glucosyltransferase became bound to heat-treated water-insoluble glucan or to heat-treated S. mutans B13 cells grown in Todd Hewitt broth, and the resulting glucan and cells adhered to a glass surface in the presence of exogenous sucrose. No other water-insoluble glucans bound significant quantities of glucosyltransferase. Glucan synthesis by free or glucan-bound glucosyltransferase was stimulated by low concentrations (1 to 5 mg ml-1) of isomaltose or water-soluble dextrans of various molecular weights, but higher concentrations (10 mg ml-1) inhibited glucan synthesis. The glucan synthesized in the presence of primer dextrans exhibited a reduced ability to adhere to a glass surface. Certain sugars such as maltose and fructose significantly lowered the yield of insoluble glucans. Preincubation of glucosyltransferase with the low molecular weight dextran T10 increased subsequent binding to S. mutans B13 insoluble glucan, whereas preincubation with higher molecular weight dextrans significantly inhibited the glucosyltransferase binding.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154120     DOI: 10.1099/00221287-116-1-51

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  11 in total

1.  A new way of producing isomalto-oligosaccharide syrup by using the transglycosylation reaction of neopullulanase.

Authors:  T Kuriki; M Yanase; H Takata; Y Takesada; T Imanaka; S Okada
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

Review 2.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

3.  Inhibition of Streptococcus mutans Biofilm Formation by the Joint Action of Oxyresveratrol and Lactobacillus casei.

Authors:  Chenglin Wang; Ruijie Huang; Jiayi Wu; Xiaoge Jiang; Qiyuan Yang; Yuheng Zhang
Journal:  Appl Environ Microbiol       Date:  2022-04-13       Impact factor: 5.005

4.  In vitro inhibition of adherence of Streptococcus mutans strains by nonadherent mutants of S. mutans 6715.

Authors:  H Murchison; S Larrimore; R Curtiss
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Inhibition of plaque and caries formation by a glucan produced by Streptococcus mutans mutant UAB108.

Authors:  K Takada; T Shiota; R Curtiss; S M Michalek
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Insoluble glucan synthesis by Streptococcus mutans serotype c strains.

Authors:  H K Kuramitsu; L Wondrack
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  Glucan-binding domain of a glucosyltransferase from Streptococcus sobrinus: isolation of a 55-kilodalton peptide from a trypsin digest of glucosyltransferase prebound to insoluble glucan.

Authors:  S Kobayashi; K Koga; O Hayashida; Y Nakano; Y Hasegawa
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Effect of a glucosyltransferase inhibitor on glucan synthesis and cellular adherence of Streptococcus mutans.

Authors:  T Koga; S Hamada; S Murakawa; A Endo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

Review 9.  Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms.

Authors:  W H Bowen; H Koo
Journal:  Caries Res       Date:  2011-02-23       Impact factor: 4.056

10.  Kaurenoic Acid from Aralia continentalis Inhibits Biofilm Formation of Streptococcus mutans.

Authors:  Seung-Il Jeong; Beom-Su Kim; Ki-Suk Keum; Kwang-Hee Lee; Sun-Young Kang; Bok-Im Park; Young-Rae Lee; Yong-Ouk You
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.